Friday, Jul 24, 2026 The claims desk. Receipts included. POWERED BY LENZ ↗
IsThis

HEALTH

The Claim

Researchers have said that psilocybin has the potential to be used as an intervention for Alzheimer's disease.

Verified by Lenz ·

The Short Version

Researchers have indeed described psilocybin as a potential intervention related to Alzheimer’s disease. Multiple peer-reviewed papers and research institutions discuss it as a plausible therapeutic candidate, based mainly on mechanistic theory, preclinical findings, and early-stage human research. The statement is accurate because it reports researcher views about potential, not established clinical benefit.

Caveats

  • “Potential” does not mean psilocybin is proven safe or effective for treating Alzheimer’s disease.
  • Much of the supporting literature is preclinical, theoretical, or based on very limited human evidence rather than large clinical trials.
  • Some current human studies focus on depression or related symptoms in people with early Alzheimer’s or mild cognitive impairment, not confirmed reversal of Alzheimer’s pathology.

The Receipts

  1. Psilocybin for the treatment of Alzheimer's disease

    PubMed Central (NIH)

  2. Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease (NCT04123314)

    ClinicalTrials.gov

  3. Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

    Alzheimers.gov (NIA)

  4. Psilocybin Maintains Better Brain Function in an Alzheimer's Disease Mouse Model by Reducing Neuroinflammation and Preserving Synapses

    PubMed Central (NIH)

  5. Psilocybin Maintains Better Brain Function in an Alzheimer's Disease Mouse Model

    Alzheimer's & Dementia (Alzheimer's Association journal)

  6. The potential of psychedelics for the treatment of Alzheimer's disease

    European Psychiatry (Elsevier)

  7. Transient multidomain functional improvement in advanced Alzheimer's disease following psilocybin administration: A case report

    Frontiers in Neuroscience

  8. Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Proposed Mechanisms of Action

    Johns Hopkins University

  9. Psychedelics and Neurodegenerative Disorders: A Review of Preclinical Studies and Potential Future Clinical Applications

    PubMed Central (NIH)

  10. The immunomodulatory effects of psychedelics in Alzheimer's disease

    Progress in Neuro-Psychopharmacology & Biological Psychiatry (ScienceDirect)

+ 14 more sources — see the full list on Lenz

Filed Under

Alzheimer's diseasePsilocybin

More Fact Checks